Johnson & Johnson, San Diego, CA, USASan Diego, CA, United States
0558: Early Systemic and Skin Pharmacodynamic Effects of Icotrokinra in Participants with Moderate-to-Severe Plaque Psoriasis: Results Through Week 24 of the Phase 3, ICONIC-LEAD Study
Sunday, October 26, 202510:30 AM - 12:30 PM Central Time
Disclosure information not submitted.
